Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Springer

Showing results (21-30 of 63) with videos related to

Pageof 7
Sort By:
Cancer Research|October 15, 1996
Gene-directed enzyme prodrug therapy with a mustard prodrug/carboxypeptidase G2 combinationR Marais, R A Spooner, Y Light, et al.
Digestion|January 1, 1989
Postprandial gastrin concentrations are higher in female patients with duodenal ulcersJ Calam, C J Springer, J C Bojarski, et al.
Cell Biophysics|January 1, 1994
Analysis of antibody-enzyme conjugate clearance by investigation of prodrug and active drug in an ADEPT clinical studyC J Springer, G K Poon, S K Sharma, et al.
Cell Biophysics|January 1, 1993
Identification of prodrug, active drug, and metabolites in an ADEPT clinical studyC J Springer, G K Poon, S K Sharma, et al.
Anti-Cancer Drug Design|June 2, 2000
Prodrugs for antibody- and gene-directed enzyme prodrug therapies (ADEPT and GDEPT)I Niculescu-Duvaz, F Friedlos, D Niculescu-Duvaz, et al.
Biochemical Pharmacology|July 7, 1992
The cytotoxicity, DNA crosslinking ability and DNA sequence selectivity of the aniline mustards melphalan, chlorambucil and 4-[bis(2-chloroethyl)amino] benzoic acidA Sunters, C J Springer, K D Bagshawe, et al.
Cell Biophysics|January 1, 1994
Antibody-directed enzyme prodrug therapy (ADEPT). A three-phase study in ovarian tumor xenograftsS K Sharma, J A Boden, C J Springer, et al.
Clinical and Experimental Pharmacology & Physiology|June 1, 1988
Effects of vasoactive intestinal polypeptide infusions on renal function in patients with liver diseaseJ Calam, R J Unwin, S Dorudi, et al.
Nature Biotechnology|January 7, 1998
A cell surface tethered enzyme improves efficiency in gene-directed enzyme prodrug therapyR Marais, R A Spooner, S M Stribbling, et al.
International Journal of Cancer|June 8, 2001
Appropriate subcellular localisation of prodrug-activating enzymes has important consequences for suicide gene therapyR A Spooner, K A Maycroft, H Paterson, et al.
Pageof 7

Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Cancer Research|October 15, 1996
Gene-directed enzyme prodrug therapy with a mustard prodrug/carboxypeptidase G2 combinationR Marais, R A Spooner, Y Light, et al.
Digestion|January 1, 1989
Postprandial gastrin concentrations are higher in female patients with duodenal ulcersJ Calam, C J Springer, J C Bojarski, et al.
Cell Biophysics|January 1, 1994
Analysis of antibody-enzyme conjugate clearance by investigation of prodrug and active drug in an ADEPT clinical studyC J Springer, G K Poon, S K Sharma, et al.
Cell Biophysics|January 1, 1993
Identification of prodrug, active drug, and metabolites in an ADEPT clinical studyC J Springer, G K Poon, S K Sharma, et al.
Anti-Cancer Drug Design|June 2, 2000
Prodrugs for antibody- and gene-directed enzyme prodrug therapies (ADEPT and GDEPT)I Niculescu-Duvaz, F Friedlos, D Niculescu-Duvaz, et al.
Biochemical Pharmacology|July 7, 1992
The cytotoxicity, DNA crosslinking ability and DNA sequence selectivity of the aniline mustards melphalan, chlorambucil and 4-[bis(2-chloroethyl)amino] benzoic acidA Sunters, C J Springer, K D Bagshawe, et al.
Cell Biophysics|January 1, 1994
Antibody-directed enzyme prodrug therapy (ADEPT). A three-phase study in ovarian tumor xenograftsS K Sharma, J A Boden, C J Springer, et al.
Clinical and Experimental Pharmacology & Physiology|June 1, 1988
Effects of vasoactive intestinal polypeptide infusions on renal function in patients with liver diseaseJ Calam, R J Unwin, S Dorudi, et al.
Nature Biotechnology|January 7, 1998
A cell surface tethered enzyme improves efficiency in gene-directed enzyme prodrug therapyR Marais, R A Spooner, S M Stribbling, et al.
International Journal of Cancer|June 8, 2001
Appropriate subcellular localisation of prodrug-activating enzymes has important consequences for suicide gene therapyR A Spooner, K A Maycroft, H Paterson, et al.
Pageof 7